Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health IT Meaningful Use Incentives Could Get Axe As House GOP Looks To Cut Spending

This article was originally published in The Pink Sheet Daily

Executive Summary

Funding bill also would prevent appropriations of funds to carry out health care reform law.

You may also be interested in...

OIG Criticism Of EHR Incentive Program Could Help GOP Target It In Fiscal Cliff Debate

HHS Office of Inspector General says CMS is vulnerable to making incentive payments to physicians and hospitals who self-report as meaningful users of electronic health records but may not be meeting requirements. House and Senate Republicans have been examining the incentive program, and this report could help put the program on the chopping block as Congress looks for cuts amid the fiscal cliff debate.

House Committee Leaders Want EHR Incentive Payments Paused Until Standards Are Strengthened

GOP leaders of the Energy & Commerce and Ways & Means committees ask CMS to halt incentive payments for meaningful use of electronic health records until true interoperable standards are developed and the criteria for demonstrating meaningful use are strengthened.

Medical Groups Call For More Flexibility, Time In EHR Stage 2 Meaningful Use

A group of 35 medical organizations, including the American Medical Association, are calling for more flexibility and time in meeting criteria for meaningful use of electronic health records as the HHS Office of the National Coordinator for Health Information Technology continues to develop stage 2 criteria.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts